90 related articles for article (PubMed ID: 18820010)
1. Chemotherapy for gastric cancer that recurs after adjuvant chemotherapy with S-1.
Shitara K; Muro K; Ura T; Takahari D; Yokota T; Sawaki A; Kawai H; Ito S; Yamamura Y
Jpn J Clin Oncol; 2008 Nov; 38(11):786-9. PubMed ID: 18820010
[TBL] [Abstract][Full Text] [Related]
2. Phase II study of the paclitaxel, cisplatin, 5-fluorouracil and leucovorin (TPFL) regimen in the treatment of advanced or metastatic gastric cancer.
Jung JY; Kwon JH; Kim JH; Song HH; Kim I; Lee KS; Kim HJ; Zang DY; Ahn JS; Lee JA; Park YI
Oncol Rep; 2009 Feb; 21(2):523-9. PubMed ID: 19148531
[TBL] [Abstract][Full Text] [Related]
3. [The effectiveness of S-1 based sequential chemotherapy as second-line treatment for advanced/recurrent gastric cancer].
Sugimoto N; Narahara H; Sakai D; Yamamoto S; Fumoto S; Yagi T; Imamura F; Iishi H; Tatsuta M
Gan To Kagaku Ryoho; 2009 Mar; 36(3):417-24. PubMed ID: 19295265
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of S-1 monotherapy in paclitaxel- and cisplatin-refractory gastric cancer.
Lee SJ; Cho SH; Yoon JY; Hwang JE; Bae WK; Shim HJ; Chung IJ
Cancer Chemother Pharmacol; 2009 Dec; 65(1):159-66. PubMed ID: 19479256
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of self-expandable metallic stent plus chemotherapy for metastatic gastric cancer with pyloric stenosis.
Shimura T; Kataoka H; Sasaki M; Yamada T; Hayashi K; Togawa S; Okumura F; Kubota E; Ohara H; Joh T
J Gastroenterol Hepatol; 2009 Aug; 24(8):1358-64. PubMed ID: 19467141
[TBL] [Abstract][Full Text] [Related]
6. Second-line chemotherapy with biweekly paclitaxel after failure of fluoropyrimidine-based treatment in patients with advanced or recurrent gastric cancer: a report from the gastrointestinal oncology group of the Tokyo cooperative oncology group, TCOG GC-0501 trial.
Koizumi W; Akiya T; Sato A; Yamaguchi K; Sakuyama T; Nakayama N; Tanabe S; Higuchi K; Sasaki T; Sekikawa T;
Jpn J Clin Oncol; 2009 Nov; 39(11):713-9. PubMed ID: 19812061
[TBL] [Abstract][Full Text] [Related]
7. A study of weekly paclitaxel plus 5-fluorouracil and cisplatin for patients with advanced or recurrent inoperable gastric cancer.
Gu Y; Shu Y; Xu Q
Biomed Pharmacother; 2009 May; 63(4):293-6. PubMed ID: 18848761
[TBL] [Abstract][Full Text] [Related]
8. New chemotherapy strategies for gastric cancer.
Kubota T
In Vivo; 2008; 22(3):273-8. PubMed ID: 18610735
[TBL] [Abstract][Full Text] [Related]
9. Multi-center phase II trial of weekly paclitaxel plus cisplatin combination chemotherapy in patients with advanced gastric and gastro-esophageal cancer.
Sun Q; Liu C; Zhong H; Zhong B; Xu H; Shen W; Wang D
Jpn J Clin Oncol; 2009 Apr; 39(4):237-43. PubMed ID: 19264768
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant chemotherapy versus surgery alone for locally advanced gastric cancer: a retrospective comparative study.
Wang LB; Shen JG; Xu CY; Chen WJ; Song XY; Yuan XM
Hepatogastroenterology; 2008; 55(86-87):1895-8. PubMed ID: 19102417
[TBL] [Abstract][Full Text] [Related]
11. Sequential salvage chemotherapy for recurrent intracranial hemangiopericytoma.
Chamberlain MC; Glantz MJ
Neurosurgery; 2008 Oct; 63(4):720-6; author reply 726-7. PubMed ID: 18981882
[TBL] [Abstract][Full Text] [Related]
12. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA
Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126
[TBL] [Abstract][Full Text] [Related]
13. Effect of adjuvant paclitaxel and carboplatin for advanced stage epithelial ovarian cancer: a population-based cohort study of all patients in western Sweden with long-term follow-up.
Akeson M; Zetterqvist BM; Dahllöf K; Brännström M; Horvath G
Acta Obstet Gynecol Scand; 2008; 87(12):1343-52. PubMed ID: 18951208
[TBL] [Abstract][Full Text] [Related]
14. R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: the influence of prior exposure to rituximab on outcome. A GEL/TAMO study.
Martín A; Conde E; Arnan M; Canales MA; Deben G; Sancho JM; Andreu R; Salar A; García-Sanchez P; Vázquez L; Nistal S; Requena MJ; Donato EM; González JA; León A; Ruiz C; Grande C; González-Barca E; Caballero MD;
Haematologica; 2008 Dec; 93(12):1829-36. PubMed ID: 18945747
[TBL] [Abstract][Full Text] [Related]
15. Phase II multicenter trial of anthracycline rechallenge with pegylated liposomal doxorubicin plus cyclophosphamide for first-line therapy of metastatic breast cancer previously treated with adjuvant anthracyclines.
Trudeau ME; Clemons MJ; Provencher L; Panasci L; Yelle L; Rayson D; Latreille J; Vandenberg T; Goel R; Zibdawi L; Rahim Y; Pouliot JF
J Clin Oncol; 2009 Dec; 27(35):5906-10. PubMed ID: 19858391
[TBL] [Abstract][Full Text] [Related]
16. [Postoperative radio-chemotherapy in locally advanced gastric cancer].
Garrido M; Bustos M; Orellana E; Madrid J; Galindo H; Sánchez C; Pimentel F; Guzmán S; Ibáñez L; Butte JM; Alvarez M; Besa P
Rev Med Chil; 2008 Jul; 136(7):844-50. PubMed ID: 18949159
[TBL] [Abstract][Full Text] [Related]
17. [The efficacy of S-1 monotherapy as a 2nd/3rd-line therapy for unresectable recurrent colon cancer: Kanagawa conference of clinical oncology (KCCO)].
Yokoyama T; Tokuhara H; Egawa T; Hashimoto O; Seki H; Koyanagi K; Bessho T
Gan To Kagaku Ryoho; 2009 Oct; 36(10):1667-70. PubMed ID: 19838025
[TBL] [Abstract][Full Text] [Related]
18. Combination chemotherapy with S-1 plus cisplatin for gastric cancer that recurs after adjuvant chemotherapy with S-1: multi-institutional retrospective analysis.
Shitara K; Morita S; Fujitani K; Kadowaki S; Takiguchi N; Hirabayashi N; Takahashi M; Takagi M; Tokunaga Y; Fukushima R; Munakata Y; Nishikawa K; Takagane A; Tanaka T; Sekishita Y; Sakamoto J; Tsuburaya A
Gastric Cancer; 2012 Jul; 15(3):245-51. PubMed ID: 21993850
[TBL] [Abstract][Full Text] [Related]
19. [Chemotherapy for patients with non-curative advanced or recurrent gastric cancer in our hospital].
Minami K; Tsutani Y; Suzuki T; Miyahara E; Kameda A; Noso Y
Gan To Kagaku Ryoho; 2008 Jan; 35(1):55-60. PubMed ID: 18195528
[TBL] [Abstract][Full Text] [Related]
20. The activity of carboplatin and paclitaxel for recurrent cervical cancer after definitive radiotherapy.
Mabuchi S; Morishige K; Fujita M; Tsutsui T; Sakata M; Enomoto T; Kimura T
Gynecol Oncol; 2009 May; 113(2):200-4. PubMed ID: 19268342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
